5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.96▲ | 0.96▲ | 0.96▲ | 0.95▲ | 0.91▲ |
MA10 | 0.95▲ | 0.95▲ | 0.95▲ | 0.90▲ | 0.93▲ |
MA20 | 0.94▲ | 0.92▲ | 0.91▲ | 0.90▲ | 0.92▲ |
MA50 | 0.89▲ | 0.89▲ | 0.90▲ | 0.91▲ | 1.10▼ |
MA100 | 0.89▲ | 0.90▲ | 0.91▲ | 0.90▲ | 1.07▼ |
MA200 | 0.91▲ | 0.90▲ | 0.91▲ | 1.03▼ | 0.77▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.004▲ | 0.006▲ | 0.008▲ | 0.012▲ | 0.014▲ |
RSI | 73.121▲ | 70.793▲ | 69.042▲ | 58.112▲ | 49.941▼ |
STOCH | 94.444▲ | 96.936▲ | 97.967▲ | 91.092▲ | 58.102 |
WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -7.692▲ | -34.211 |
CCI | 250.807▲ | 241.016▲ | 224.876▲ | 126.155▲ | 40.943 |
Sunday, June 15, 2025 05:00 PM
Discover why Climb Global Solutions (CLMB) shows 25% upside potential, driven by strong organic growth, strategic acquisitions & IT software market expansion.
|
Thursday, May 22, 2025 05:42 AM
DSS, Inc. announced its financial results for Q1 2025, showcasing significant growth and improvements in its operations. The company achieved a 28% year-over-year revenue increase, driven by a 30% ...
|
Monday, March 24, 2025 05:03 PM
DSS, Inc. (NYSE: DSS), a ten percent owner of Impact Biomedical Inc. (NASDAQ:IBO), has recently executed a series of stock transactions, according to a recent SEC filing.Impact Biomedical ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
13/06/25 | 0.91 | 0.99 | 0.91 | 0.97 | 7,300 |
12/06/25 | 0.93 | 0.97 | 0.93 | 0.97 | 11,700 |
11/06/25 | 0.924 | 0.94 | 0.91 | 0.94 | 2,900 |
10/06/25 | 0.925 | 0.925 | 0.925 | 0.925 | 5,463 |
09/06/25 | 0.852 | 0.939 | 0.852 | 0.939 | 17,000 |
06/06/25 | 0.825 | 0.86 | 0.825 | 0.852 | 5,200 |
05/06/25 | 0.83 | 0.855 | 0.83 | 0.839 | 7,400 |
04/06/25 | 0.89 | 0.89 | 0.79 | 0.83 | 40,600 |
03/06/25 | 0.875 | 0.8813 | 0.87 | 0.8813 | 4,877 |
02/06/25 | 0.89 | 0.8999 | 0.8601 | 0.8601 | 2,628 |
|
|
||||
|
|
||||
|
|